Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study

Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study

Background. Tumour necrosis factor alpha inhibitors are widely used in the treatment  of juvenile idiopathic arthritis (JIA). To achieve maximum efficiency of genetically engineered biologic drugs, it is necessary to study predictors of the response to therapy. Objective. Our aim was to identify ear...

Full description

Bibliographic Details
Main Authors: Ekaterina I. Alexeeva, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Tatyana V. Sleptsova, Rina V. Denisova, Margarita A. Soloshenko, Olga L. Lomakina, Anna N. Fetisova, Mariya G. Rudnickaya, Dariya D. Vankova, Yuri M. Dyakonov, Alina A. Alshevskaya, Andrei V. Moskalev, Anna V. Mamutova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2018-12-01
Series:Вопросы современной педиатрии
Subjects:
дети
ювенильный идиопатический артрит
терапия
предикторы ответа
генно-инженерный биологический препарат
адалимумаб
Online Access:https://vsp.spr-journal.ru/jour/article/view/1954

Similar Items

Similar Items